Yongkui Jing
6PUBLICATIONS
6CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Mar 24, 2026
Optimization of 4-Aniline Substituted Pyrido[3,2-<i>d</i>]pyrimidine Derivatives as Pim/Mnk Dual Inhibitors with Antileukemia Activity.Kun Xing, Shujun Li, Shuwei Zuo
|Aug 09, 2024
Discovery of Novel Mcl-1 Inhibitors with a 3-Substituted-1<i>H</i>-indole-1-yl Moiety Binding to the P1-P3 Pockets to Induce Apoptosis in Acute Myeloid Leukemia Cells.Hongguang Deng, Jingyi Zhang, Liang Liu
|Jan 18, 2024
Design and Synthesis of Dual-Targeting Inhibitors of sEH and HDAC6 for the Treatment of Neuropathic Pain and Lipopolysaccharide-Induced Mortality.Yuanguang Chen, Jianwen Sun, Hua Tong
|Feb 04, 2023
The GSK3β/Mcl-1 axis is regulated by both FLT3-ITD and Axl and determines the apoptosis induction abilities of FLT3-ITD inhibitors.Yang Qiu, Ying Li, Meng Chai
|Apr 21, 2022
Artesunate improves venetoclax plus cytarabine AML cell targeting by regulating the Noxa/Bim/Mcl-1/p-Chk1 axis.Jingyi Zhang, Yuetong Wang, Chujie Yin
|Sep 13, 2021
Optimization of 4,6-Disubstituted Pyrido[3,2-<i>d</i>]pyrimidines as Dual MNK/PIM Inhibitors to Inhibit Leukemia Cell Growth.Yu Han, Huimin Zhang, Shuxiang Wang
Pageof 1
